EARLY findings show that the drug tirzepatide performed better overall across trials, both for blood sugar control and weight loss.
The researchers of the study, presented at the European Association for the Study of Diabetes conference, say tirzepatide may help with the shortage of semaglutide.
The above article was sent to subscribers in Pharmacy Daily's issue from 27 Sep 23
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 27 Sep 23
